The genetic spectrum and the evaluation of CADASIL screening scale in Chinese patients with NOTCH3 mutations
The genetic spectrum and the evaluation of CADASIL screening scale in Chinese patients with NOTCH3 mutations
复制标题
中国NOTCH3突变患者基因谱及CADASIL筛查量表评价
DOI:
10.1016/j.jns.2015.04.047
复制
发表时间:
2015-07-15
影响因子:
4.4
通讯作者:
Wang, Zhaoxia
中科院分区:
文献类型:
--
作者:
Liu, Xiao;Zuo, Yuehuan;Wang, Zhaoxia
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited small artery disease caused by NOTCH3 gene mutation. Here we report clinical, pathological and genetic profiles of 29 newly-diagnosed CADASIL patients, evaluation of the CADASIL scale in Chinese CADASIL patients, and reanalysis of all reported mainland Chinese patients with identified NOTCH3 gene mutation. We found two novel mutations (p.C134G and p.C291Y) and 13 reported NOTCH3 mutations in the newly-diagnosed group. CADASIL scale score was less than the cutoff score in 19 of 53 Chinese patients with NOTCH3 mutation, generating only a sensitivity of 64.1%. At the time of study, the total number of genetically confirmed CADASIL cases reached 158 from 97 unrelated mainland Chinese families, with 9/97 (9.3%) sporadic patients. The NOTCH3 gene mutation profile showed 43 mutations, with hotspots in exon 4, followed by exon 3. The considerable variability in onset age and CADASIL scale score in patients carrying the same NOTCH3 missense mutation suggested no obvious phenotype-genotype correlation. In conclusion, we report two novel mutations which expand the NOTCH3 mutational spectrum. Exons 4 and 3 are hotspots in mainland Chinese patients with NOTCH3 mutation. The low sensitivity of CADASIL scale in our patients group indicated that the CADASIL scale should be refined according to the clinical characteristics of Chinese CADASIL patients when used in Chinese populations. (C) 2015 Elsevier B.V. All rights reserved.